Use of high-dose early parenteral lipid in very preterm infants

We read with great interest the prospective randomized trial on use of high dose early parenteral lipid in very preterm infants by the HELP trial investigators.1 This trial addresses the clinical dilemma regarding the optimal initial dose for lipid administration in preterm infants. The authors reported a decrease in early postnatal weight loss with higher starting dose of lipids, similar to previously published data.2 However, we would like to highlight a few issues and request a clarification.

Source: The Journal of Pediatrics - February 1, 2021 Category: Pediatrics Authors: Khushboo Kanwal, Anish Pillai, Nandkishor Kabra Tags: Letters to the Editor Source Type: research